echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Positive day clear TQC3721 declared clinically used for slow-blocking lungs and asthma

    Positive day clear TQC3721 declared clinically used for slow-blocking lungs and asthma

    • Last Update: 2021-01-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 8, CDE's official website showed that a clinical application for the new class 1 drug ,TQC3721 mixed suspension for inhalation was accepted.
    the drug is a new class 1 drug in the field of breathing.
    Insight database shows that the current day clear has been listed in the product to anti-infective drugs mainly, in the research products to anti-tumor drugs mainly, in addition to these two areas, respiratory drugs are also a major force in the field of day clear.
    from the Insight database (), there are currently 2 main varieties of new class 1 drugs in the respiratory field under development, TQC3721 and TQC3564.
    the former for obstructive pulmonary disease and asthma, while the latter for asthma, allergic rhinitis and allergic rhinitis.
    TQC3721, which is currently clinically declared, has not disclosed any other information other than adaptation.
    another new drug, TQC3564, was approved for clinical use in 2019 Q3, and 2020 Q3 completed Phase 1 clinical, which has not yet been initiated.
    details of the TQC3564 project
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.